#PregnancyHealth #Hypertension #PhysicalActivity
www.medscape.com
HBP Risk in Pregnancy Reduced by 30% With Light Activity, Plenty of Sleep
It doesn't take a heavy workout regimen to reduce risk for hypertension during pregnancy, according to a new analysis that found light activity, limited sedentary activity, and a good night's sleep may cut that risk by 30%.
#Hypertension #CardiovascularHealth #YoungAdults
www.medscape.com
Higher Blood Pressure in Young Adults Linked to Heart and Kidney Disease at Midlife
Elevated blood pressure during early adulthood was associated with a higher risk for heart and kidney diseases in midlife, according to a new study, confirming the wisdom of guidelines recommending treatment for young adults with hypertension.
#Diabetes #Hypertension #CardiovascularHealth
www.medscape.com
Early Hypertension Linked to a Poorer Prognosis in T2D
In patients with type 2 diabetes (T2D), both young-onset hypertension (onset before the age of 45 years) and late-onset hypertension (onset at the age of 45 years or later) were associated with higher risks for cardiovascular disease (CVD), congestive heart failure, chronic kidney disease, and all-cause mortality, with young-onset hypertension linked to poorer outcomes.
S
#Hypertension #Healthcare #Innovation
www.streetinsider.com
Idorsia's JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
* Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.
#Hypertension #HeartHealth #Pharmaceuticals
www.benzinga.com
Idorsia's JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity NewsletterIdorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.
